198 related articles for article (PubMed ID: 20870969)
1. Genetic predisposition to long-term nondiabetic deteriorations in glucose homeostasis: Ten-year follow-up of the GLACIER study.
Renström F; Shungin D; Johansson I; ; Florez JC; Hallmans G; Hu FB; Franks PW
Diabetes; 2011 Jan; 60(1):345-54. PubMed ID: 20870969
[TBL] [Abstract][Full Text] [Related]
2. Common genetic determinants of glucose homeostasis in healthy children: the European Youth Heart Study.
Kelliny C; Ekelund U; Andersen LB; Brage S; Loos RJ; Wareham NJ; Langenberg C
Diabetes; 2009 Dec; 58(12):2939-45. PubMed ID: 19741166
[TBL] [Abstract][Full Text] [Related]
3. Effects of genetic variants previously associated with fasting glucose and insulin in the Diabetes Prevention Program.
Florez JC; Jablonski KA; McAteer JB; Franks PW; Mason CC; Mather K; Horton E; Goldberg R; Dabelea D; Kahn SE; Arakaki RF; Shuldiner AR; Knowler WC;
PLoS One; 2012; 7(9):e44424. PubMed ID: 22984506
[TBL] [Abstract][Full Text] [Related]
4. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk.
Dupuis J; Langenberg C; Prokopenko I; Saxena R; Soranzo N; Jackson AU; Wheeler E; Glazer NL; Bouatia-Naji N; Gloyn AL; Lindgren CM; Mägi R; Morris AP; Randall J; Johnson T; Elliott P; Rybin D; Thorleifsson G; Steinthorsdottir V; Henneman P; Grallert H; Dehghan A; Hottenga JJ; Franklin CS; Navarro P; Song K; Goel A; Perry JR; Egan JM; Lajunen T; Grarup N; Sparsø T; Doney A; Voight BF; Stringham HM; Li M; Kanoni S; Shrader P; Cavalcanti-Proença C; Kumari M; Qi L; Timpson NJ; Gieger C; Zabena C; Rocheleau G; Ingelsson E; An P; O'Connell J; Luan J; Elliott A; McCarroll SA; Payne F; Roccasecca RM; Pattou F; Sethupathy P; Ardlie K; Ariyurek Y; Balkau B; Barter P; Beilby JP; Ben-Shlomo Y; Benediktsson R; Bennett AJ; Bergmann S; Bochud M; Boerwinkle E; Bonnefond A; Bonnycastle LL; Borch-Johnsen K; Böttcher Y; Brunner E; Bumpstead SJ; Charpentier G; Chen YD; Chines P; Clarke R; Coin LJ; Cooper MN; Cornelis M; Crawford G; Crisponi L; Day IN; de Geus EJ; Delplanque J; Dina C; Erdos MR; Fedson AC; Fischer-Rosinsky A; Forouhi NG; Fox CS; Frants R; Franzosi MG; Galan P; Goodarzi MO; Graessler J; Groves CJ; Grundy S; Gwilliam R; Gyllensten U; Hadjadj S; Hallmans G; Hammond N; Han X; Hartikainen AL; Hassanali N; Hayward C; Heath SC; Hercberg S; Herder C; Hicks AA; Hillman DR; Hingorani AD; Hofman A; Hui J; Hung J; Isomaa B; Johnson PR; Jørgensen T; Jula A; Kaakinen M; Kaprio J; Kesaniemi YA; Kivimaki M; Knight B; Koskinen S; Kovacs P; Kyvik KO; Lathrop GM; Lawlor DA; Le Bacquer O; Lecoeur C; Li Y; Lyssenko V; Mahley R; Mangino M; Manning AK; Martínez-Larrad MT; McAteer JB; McCulloch LJ; McPherson R; Meisinger C; Melzer D; Meyre D; Mitchell BD; Morken MA; Mukherjee S; Naitza S; Narisu N; Neville MJ; Oostra BA; Orrù M; Pakyz R; Palmer CN; Paolisso G; Pattaro C; Pearson D; Peden JF; Pedersen NL; Perola M; Pfeiffer AF; Pichler I; Polasek O; Posthuma D; Potter SC; Pouta A; Province MA; Psaty BM; Rathmann W; Rayner NW; Rice K; Ripatti S; Rivadeneira F; Roden M; Rolandsson O; Sandbaek A; Sandhu M; Sanna S; Sayer AA; Scheet P; Scott LJ; Seedorf U; Sharp SJ; Shields B; Sigurethsson G; Sijbrands EJ; Silveira A; Simpson L; Singleton A; Smith NL; Sovio U; Swift A; Syddall H; Syvänen AC; Tanaka T; Thorand B; Tichet J; Tönjes A; Tuomi T; Uitterlinden AG; van Dijk KW; van Hoek M; Varma D; Visvikis-Siest S; Vitart V; Vogelzangs N; Waeber G; Wagner PJ; Walley A; Walters GB; Ward KL; Watkins H; Weedon MN; Wild SH; Willemsen G; Witteman JC; Yarnell JW; Zeggini E; Zelenika D; Zethelius B; Zhai G; Zhao JH; Zillikens MC; ; ; ; Borecki IB; Loos RJ; Meneton P; Magnusson PK; Nathan DM; Williams GH; Hattersley AT; Silander K; Salomaa V; Smith GD; Bornstein SR; Schwarz P; Spranger J; Karpe F; Shuldiner AR; Cooper C; Dedoussis GV; Serrano-Ríos M; Morris AD; Lind L; Palmer LJ; Hu FB; Franks PW; Ebrahim S; Marmot M; Kao WH; Pankow JS; Sampson MJ; Kuusisto J; Laakso M; Hansen T; Pedersen O; Pramstaller PP; Wichmann HE; Illig T; Rudan I; Wright AF; Stumvoll M; Campbell H; Wilson JF; ; ; Bergman RN; Buchanan TA; Collins FS; Mohlke KL; Tuomilehto J; Valle TT; Altshuler D; Rotter JI; Siscovick DS; Penninx BW; Boomsma DI; Deloukas P; Spector TD; Frayling TM; Ferrucci L; Kong A; Thorsteinsdottir U; Stefansson K; van Duijn CM; Aulchenko YS; Cao A; Scuteri A; Schlessinger D; Uda M; Ruokonen A; Jarvelin MR; Waterworth DM; Vollenweider P; Peltonen L; Mooser V; Abecasis GR; Wareham NJ; Sladek R; Froguel P; Watanabe RM; Meigs JB; Groop L; Boehnke M; McCarthy MI; Florez JC; Barroso I
Nat Genet; 2010 Feb; 42(2):105-16. PubMed ID: 20081858
[TBL] [Abstract][Full Text] [Related]
5. Variants of ADRA2A are associated with fasting glucose, blood pressure, body mass index and type 2 diabetes risk: meta-analysis of four prospective studies.
Talmud PJ; Cooper JA; Gaunt T; Holmes MV; Shah S; Palmen J; Drenos F; Shah T; Kumari M; Kivimaki M; Whittaker J; Lawlor DA; Day IN; Hingorani AD; Casas JP; Humphries SE
Diabetologia; 2011 Jul; 54(7):1710-9. PubMed ID: 21455730
[TBL] [Abstract][Full Text] [Related]
6. The associations of daylight and melatonin receptor 1B gene rs10830963 variant with glycemic traits: the prospective PPP-Botnia study.
Haljas K; Hakaste L; Lahti J; Isomaa B; Groop L; Tuomi T; Räikkönen K
Ann Med; 2019 Feb; 51(1):58-67. PubMed ID: 30592226
[TBL] [Abstract][Full Text] [Related]
7. Variants in MTNR1B influence fasting glucose levels.
Prokopenko I; Langenberg C; Florez JC; Saxena R; Soranzo N; Thorleifsson G; Loos RJ; Manning AK; Jackson AU; Aulchenko Y; Potter SC; Erdos MR; Sanna S; Hottenga JJ; Wheeler E; Kaakinen M; Lyssenko V; Chen WM; Ahmadi K; Beckmann JS; Bergman RN; Bochud M; Bonnycastle LL; Buchanan TA; Cao A; Cervino A; Coin L; Collins FS; Crisponi L; de Geus EJ; Dehghan A; Deloukas P; Doney AS; Elliott P; Freimer N; Gateva V; Herder C; Hofman A; Hughes TE; Hunt S; Illig T; Inouye M; Isomaa B; Johnson T; Kong A; Krestyaninova M; Kuusisto J; Laakso M; Lim N; Lindblad U; Lindgren CM; McCann OT; Mohlke KL; Morris AD; Naitza S; Orrù M; Palmer CN; Pouta A; Randall J; Rathmann W; Saramies J; Scheet P; Scott LJ; Scuteri A; Sharp S; Sijbrands E; Smit JH; Song K; Steinthorsdottir V; Stringham HM; Tuomi T; Tuomilehto J; Uitterlinden AG; Voight BF; Waterworth D; Wichmann HE; Willemsen G; Witteman JC; Yuan X; Zhao JH; Zeggini E; Schlessinger D; Sandhu M; Boomsma DI; Uda M; Spector TD; Penninx BW; Altshuler D; Vollenweider P; Jarvelin MR; Lakatta E; Waeber G; Fox CS; Peltonen L; Groop LC; Mooser V; Cupples LA; Thorsteinsdottir U; Boehnke M; Barroso I; Van Duijn C; Dupuis J; Watanabe RM; Stefansson K; McCarthy MI; Wareham NJ; Meigs JB; Abecasis GR
Nat Genet; 2009 Jan; 41(1):77-81. PubMed ID: 19060907
[TBL] [Abstract][Full Text] [Related]
8. Common polymorphisms in MTNR1B, G6PC2 and GCK are associated with increased fasting plasma glucose and impaired beta-cell function in Chinese subjects.
Tam CH; Ho JS; Wang Y; Lee HM; Lam VK; Germer S; Martin M; So WY; Ma RC; Chan JC; Ng MC
PLoS One; 2010 Jul; 5(7):e11428. PubMed ID: 20628598
[TBL] [Abstract][Full Text] [Related]
9. Established BMI-associated genetic variants and their prospective associations with BMI and other cardiometabolic traits: the GLACIER Study.
Ahmad S; Poveda A; Shungin D; Barroso I; Hallmans G; Renström F; Franks PW
Int J Obes (Lond); 2016 Sep; 40(9):1346-52. PubMed ID: 27121252
[TBL] [Abstract][Full Text] [Related]
10. The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population.
Vaxillaire M; Cavalcanti-Proença C; Dechaume A; Tichet J; Marre M; Balkau B; Froguel P;
Diabetes; 2008 Aug; 57(8):2253-7. PubMed ID: 18556336
[TBL] [Abstract][Full Text] [Related]
11. Meta-analyses of the association of G6PC2 allele variants with elevated fasting glucose and type 2 diabetes.
Shi Y; Li Y; Wang J; Wang C; Fan J; Zhao J; Yin L; Liu X; Zhang D; Li L
PLoS One; 2017; 12(7):e0181232. PubMed ID: 28704540
[TBL] [Abstract][Full Text] [Related]
12. Glucose-raising genetic variants in MADD and ADCY5 impair conversion of proinsulin to insulin.
Wagner R; Dudziak K; Herzberg-Schäfer SA; Machicao F; Stefan N; Staiger H; Häring HU; Fritsche A
PLoS One; 2011; 6(8):e23639. PubMed ID: 21887289
[TBL] [Abstract][Full Text] [Related]
13. Combined effects of single-nucleotide polymorphisms in GCK, GCKR, G6PC2 and MTNR1B on fasting plasma glucose and type 2 diabetes risk.
Reiling E; van 't Riet E; Groenewoud MJ; Welschen LM; van Hove EC; Nijpels G; Maassen JA; Dekker JM; 't Hart LM
Diabetologia; 2009 Sep; 52(9):1866-70. PubMed ID: 19533084
[TBL] [Abstract][Full Text] [Related]
14. Association of risk variants for type 2 diabetes and hyperglycemia with gestational diabetes.
Huopio H; Cederberg H; Vangipurapu J; Hakkarainen H; Pääkkönen M; Kuulasmaa T; Heinonen S; Laakso M
Eur J Endocrinol; 2013 Sep; 169(3):291-7. PubMed ID: 23761423
[TBL] [Abstract][Full Text] [Related]
15. Additive genetic effect of GCKR, G6PC2, and SLC30A8 variants on fasting glucose levels and risk of type 2 diabetes.
Chen G; Shriner D; Zhang J; Zhou J; Adikaram P; Doumatey AP; Bentley AR; Adeyemo A; Rotimi CN
PLoS One; 2022; 17(6):e0269378. PubMed ID: 35657990
[TBL] [Abstract][Full Text] [Related]
16. Nonfasting glucose, ischemic heart disease, and myocardial infarction: a Mendelian randomization study.
Benn M; Tybjaerg-Hansen A; McCarthy MI; Jensen GB; Grande P; Nordestgaard BG
J Am Coll Cardiol; 2012 Jun; 59(25):2356-65. PubMed ID: 22698489
[TBL] [Abstract][Full Text] [Related]
17. Season-dependent associations of circadian rhythm-regulating loci (CRY1, CRY2 and MTNR1B) and glucose homeostasis: the GLACIER Study.
Renström F; Koivula RW; Varga TV; Hallmans G; Mulder H; Florez JC; Hu FB; Franks PW
Diabetologia; 2015 May; 58(5):997-1005. PubMed ID: 25707907
[TBL] [Abstract][Full Text] [Related]
18. Effects of GCK, GCKR, G6PC2 and MTNR1B variants on glucose metabolism and insulin secretion.
Hu C; Zhang R; Wang C; Yu W; Lu J; Ma X; Wang J; Jiang F; Tang S; Bao Y; Xiang K; Jia W
PLoS One; 2010 Jul; 5(7):e11761. PubMed ID: 20668700
[TBL] [Abstract][Full Text] [Related]
19. Genetic risk score of 46 type 2 diabetes risk variants associates with changes in plasma glucose and estimates of pancreatic β-cell function over 5 years of follow-up.
Andersson EA; Allin KH; Sandholt CH; Borglykke A; Lau CJ; Ribel-Madsen R; Sparsø T; Justesen JM; Harder MN; Jørgensen ME; Jørgensen T; Hansen T; Pedersen O
Diabetes; 2013 Oct; 62(10):3610-7. PubMed ID: 23835328
[TBL] [Abstract][Full Text] [Related]
20. Large scale meta-analyses of fasting plasma glucose raising variants in GCK, GCKR, MTNR1B and G6PC2 and their impacts on type 2 diabetes mellitus risk.
Wang H; Liu L; Zhao J; Cui G; Chen C; Ding H; Wang DW
PLoS One; 2013; 8(6):e67665. PubMed ID: 23840762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
